Search

Search Results
Results 91 - 100 of 133 for Acne
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Retrieve intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Zumenon intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Vttack intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Dizole One (fluconazole) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooke (drospirenone 3 mg and ethinylestradiol 20 micrograms) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Drug - 15 Mar 2023
    Consumer Medicine Information (CMI) about Diphereline (triptorelin embonate) intended for persons living in Australia.
  • Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Triphasil (Levonorgestrel and Ethinylestradiol Tablets) intended for persons living in Australia.
  • Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor-1 (Ethinylestradiol and Norethisterone) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.